TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
unsuccessful
Official procurement procedure

Licence variation: spironolactone for acne in women

Health services
Pharmacy services
Yorkshire & Humber (UKE)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "Licence variation: spironolactone for acne in women". Published status: unsuccessful. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
unsuccessful
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
49.6Bids / Report
38.2% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 752 active published awards; 747 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statusunsuccessful
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published17 Jan 2025, 15:30 GMT
Last source update17 Jan 2025, 15:30 GMT
Recurring procurementNot published
ClassificationHealth services, Pharmacy services
Delivery area
Yorkshire & Humber (UKE)
OCIDocds-h6vhtk-045808
What is being bought
NHS England required a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
What changed
From the official release history
  1. Status changed to unsuccessful
    17 Jan 2025, 15:30 GMT
  2. Official notice release published
    17 Jan 2025, 15:30 GMT
  3. Buyer information updated
    17 Jan 2025, 15:30 GMT
  4. tender value changed
    2 Oct 2024, 16:31 BST
  5. Status changed to published status
    2 Oct 2024, 16:31 BST
  6. Official notice release published
    2 Oct 2024, 16:31 BST
  7. Submission deadline changed to published date
    2 Oct 2024, 16:31 BST
  8. Published value updated to £171,500
    5 Sept 2024, 19:21 BST
  9. Status changed to active
    5 Sept 2024, 19:21 BST
  10. Official notice release published
    5 Sept 2024, 19:21 BST
  11. Submission deadline changed to 7 Oct 2024, 12:00 BST
    5 Sept 2024, 19:21 BST
  12. Buyer information updated
    5 Sept 2024, 19:21 BST
  13. Status changed to published status
    2 Jul 2024, 17:16 BST
  14. Official notice release published
    2 Jul 2024, 17:16 BST
  15. Submission deadline changed to published date
    2 Jul 2024, 17:16 BST
  16. Buyer information updated
    2 Jul 2024, 17:16 BST
  17. Status changed to active
    19 Jun 2024, 16:45 BST
  18. Official notice release published
    19 Jun 2024, 16:45 BST
  19. Submission deadline changed to 31 Jul 2024, 12:00 BST
    19 Jun 2024, 16:45 BST
  20. Status changed to planned
    8 May 2024, 15:33 BST
  21. Official notice release published
    8 May 2024, 15:33 BST
  22. Buyer information updated
    8 May 2024, 15:33 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    NHS England required a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    17 Jan 2025, 15:30 GMT
  2. Award unsuccessful
    Not published · Not published
Commercial outcome and competition
Awards
Awarded supplier not published
Not published · Not published · unsuccessful
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-118033
View buyer profile

  • NHS England
    buyer

    7&8 Wellington Place, Leeds, UKE, LS1 4AP
    leigh.parker1@nhs.net

  • The High Court
    reviewBody
    reviewContactPoint

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published